The Lancet. Public health
-
The Lancet. Public health · Oct 2020
Observational StudyHospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study.
The COVID-19 pandemic has had a profound effect on general health care. We aimed to evaluate the effect of a nationwide lockdown in France on admissions to hospital for acute myocardial infarction, by patient characteristics and regional prevalence of the pandemic. ⋯ Recherche Hospitalo-Universitaire en Santé iVasc.
-
The Lancet. Public health · Sep 2020
Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study.
Since October, 2017 (and until October, 2020), pre-exposure prophylaxis (PrEP) has only been available in England, UK, through the PrEP Impact Trial, by purchasing it from some genitourinary medicine clinics, or via online sources. Here we report changes from 2013 to 2018 in PrEP and postexposure prophylaxis (PEP) awareness and use among HIV-negative gay, bisexual, and other men who have sex with men (MSM) and assess predictors of PrEP initiation. ⋯ National Institute for Health Research.
-
The Lancet. Public health · Sep 2020
Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey.
Human papillomavirus (HPV) vaccine uptake among US adolescents is primarily dependent on the intent of their parents. To the best of our knowledge, an analysis quantifying parental intent to initiate and complete the HPV vaccine series in the USA at both the national and state level has not been done. We aim to estimate parental intent to initiate and complete the HPV vaccine series at the national-level and state-level and to identify reasons for lack of intent to initiate and complete the vaccine series. ⋯ US National Cancer Institute.
-
The Lancet. Public health · Aug 2020
Multicenter Study Observational StudyThe effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study.
The COVID-19 pandemic has placed unprecedented strain on health-care systems. Frailty is being used in clinical decision making for patients with COVID-19, yet the prevalence and effect of frailty in people with COVID-19 is not known. In the COVID-19 in Older PEople (COPE) study we aimed to establish the prevalence of frailty in patients with COVID-19 who were admitted to hospital and investigate its association with mortality and duration of hospital stay. ⋯ None.